Comparison of the burden of familial hypercholesterolemia between two cohorts of French Canadians hospitalized 25 years apart for coronary heart disease

Genetic burden linked to founder effects in Saguenay-Lac-Saint-Jean illustrates the importance of genetic screening test availability

(2021) Mbarka Bchetnia et al.   JOURNAL OF MEDICAL GENETICS

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

(2021) Antonio J. Vallejo-Vaz et al.   LANCET

Tobacco Use Prevalence and Transitions From 2013 to 2018 Among Adults With a History of Cardiovascular Disease

(2021) Lindsay M. Reynolds et al.   Journal of the American Heart Association

Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease

(2020) Pengwei Hu et al.   CIRCULATION

Evinacumab in Patients with Refractory Hypercholesterolemia

(2020) Robert S. Rosenson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia

(2019) Sofía Perez-Calahorra et al.   ATHEROSCLEROSIS

Cigarette consumption estimates for 71 countries from 1970 to 2015: systematic collection of comparable data to facilitate quasi-experimental evaluations of national and global tobacco control interventions

(2019) Steven J Hoffman et al.   BMJ-British Medical Journal

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Simplified Canadian Definition for Familial Hypercholesterolemia

(2018) Isabelle Ruel et al.   CANADIAN JOURNAL OF CARDIOLOGY

Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab

(2018) Paul M Ridker et al.   Journal of Clinical Lipidology

Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018

(2018) Liam R. Brunham et al.   CANADIAN JOURNAL OF CARDIOLOGY

Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia

(2017) G. Kees Hovingh et al.   Journal of Clinical Lipidology

Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis

(2017) Leo E Akioyamen et al.   BMJ Open

Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia PhenotypeClinical Perspective

(2016) Amanda M. Perak et al.   CIRCULATION

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

The LDL Receptor

(2009) Joseph L. Goldstein et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY